Autolomous Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.38M

  • Investors
  • 7

Autolomous General Information

Description

Developer of a healthcare manufacturing data management platform intended to support the development and delivery of advanced medicines. The company offers laboratory-friendly software that securely transfers manufacturing data to a cloud-based system with immutable data tracking, scheduling tools, and digital quality approvals, enabling therapy developers to manage manufacturing processes efficiently and improve the accessibility of advanced medicines.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Bloomsbury Place
  • London WC1A 2QA
  • England, United Kingdom
+44 020
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Corporate Office
  • 2 Bloomsbury Place
  • London WC1A 2QA
  • England, United Kingdom
+44 020

Autolomous Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Autolomous Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Mar-2025 $4.38M Completed Generating Revenue
7. Angel (individual) 29-Sep-2024 Completed Generating Revenue
6. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
5. Grant 12-Jun-2023 Completed Generating Revenue
4. Early Stage VC (Series A) 27-Dec-2022 Completed Generating Revenue
3. Grant 01-Apr-2021 Completed Generating Revenue
2. Grant 04-Jan-2021 $269K $852K Completed Generating Revenue
1. Seed Round 24-Jul-2020 $852K $852K Completed Generating Revenue
To view Autolomous’s complete valuation and funding history, request access »

Autolomous Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C2 Preferred Ordinary
C1 Preferred Ordinary
B Ordinary
B Ordinary 3,831 $0.013202 $215.94 $215.94 1x $215.94 2.53%
Ordinary 11,337 $0.013202 $79.21 $79.21 1x $79.21 7.48%
To view Autolomous’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Autolomous Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Autolomous Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
İstanbul Portföy Yönetimi Asset Manager Minority
BioTools Innovator Accelerator/Incubator Minority
MedTech Innovator Accelerator/Incubator
Aescuvest Venture Capital Minority
Health Innovations Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Autolomous FAQs

  • When was Autolomous founded?

    Autolomous was founded in 2019.

  • Where is Autolomous headquartered?

    Autolomous is headquartered in London, United Kingdom.

  • What is the size of Autolomous?

    Autolomous has 41 total employees.

  • What industry is Autolomous in?

    Autolomous’s primary industry is Other Healthcare Technology Systems.

  • Is Autolomous a private or public company?

    Autolomous is a Private company.

  • What is Autolomous’s current revenue?

    The current revenue for Autolomous is .

  • How much funding has Autolomous raised over time?

    Autolomous has raised $12.4M.

  • Who are Autolomous’s investors?

    İstanbul Portföy Yönetimi, BioTools Innovator, MedTech Innovator, Aescuvest, and Health Innovations are 5 of 7 investors who have invested in Autolomous.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process